Centre To Purchase 30 Crore COVID Vaccine Doses from Hyderabad Firm

 - Sakshi Post

HYDERABAD: The Centre is slated to purchase  30 crore COVID vaccine doses from Hyderabad based firm. In a statement released on Thursday, the Union Health Ministry has finalised arrangements with Hyderabad- based vaccine manufacturer Biological-E to reserve 30 crore of COVID-19 vaccine doses.

These vaccine doses will be manufactured and stockpiled by M/s Biological-E from August to December this year. An advance payment of Rs 1,500 crore was also made to M/s Biological-E.
The COVID-19 vaccine of Biological-E is currently undergoing Phase-3 clinical trials after showing promising results in Phase-1 and 2 clinical trials and the vaccine is likely to be available in the next few months.
The proposal of the company was examined and recommended for approval after due diligence by the National Expert Group on Vaccine Administration for COVID-19, (NEGVAC).
The arrangement with M/s Biological-E is part of the wider endeavour of the Government of India to encourage indigenous vaccine manufacturers by providing them support in Research & Development (R&D) and also financial support,' the Ministry said.

Department of Biotechnology has not only provided financial assistance in terms of grant-in-aid of over Rs 100 cr but has also partnered with Biological-E to conduct all animal challenge and assay studies through its Research Institute Translational Health Science Technology Institute (THSTI), Faridabad.

Also Read: Serum Institute Seeks DGCI Permission To Manufacture Sputnik-V

Back to Top